Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Aricept
Generic name / active ingredient
donepezil
Dosage-form class
Oral film-coated tablets: 5 mg, 10 mg and 23 mg; orally disintegrating tablets: 5 mg and 10 mg (as listed in the current U.S. label)
Route
Oral
Record reviewed
2026-08-20

Copy from the pack in hand

Source-linked reading points

  • First check ARICEPT, donepezil, tablet or orally disintegrating tablet, labelled strength per unit and target market. A “5”, “10” or “23” alone does not say how a person should use it or prove interchangeability with another pack.
  • The current U.S. label distinguishes 5, 10 and 23 mg tablets and 5 and 10 mg orally disintegrating tablets; it states that the 23 mg tablet should not be split, crushed or chewed. Another market or product version needs checking against the current label for that exact product.
  • The label identifies issues that may require attention involving heart rate, gastrointestinal effects, weight, anaesthesia and combinations with anticholinergic or other cholinergic medicines. When multiple memory, sleep, cold, pain or bladder products are at home, bring the complete list to a pharmacist rather than self-combining, substituting or stopping.
  • For fainting, a marked heart-rate concern, persistent vomiting/dehydration, black stools or another acute symptom, seek timely medical assessment; a webpage and historical label cannot replace urgent judgement.

Reviewed presentation examples — compare every field

  • 5 mg; 30-tablet bottleNDC 62856-245-30
  • 10 mg; 30-tablet bottleNDC 62856-246-30
  • 23 mg; 30-tablet bottleNDC 62856-247-30
  • 5 mg; 30-tablet unit-dose blister carton (10 × 3)NDC 62856-831-30
  • 10 mg; 30-tablet unit-dose blister carton (10 × 3)NDC 62856-832-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-20
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image